- Home
- IMMP vs PSTL Comparison
IMMP vs PSTL Comparison
Compare IMMP & PSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- PSTL
- Stock Information
- Founded
- IMMP 1987
- PSTL 2018
- Country
- IMMP Australia
- PSTL United States
- Employees
- IMMP N/A
- PSTL N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- PSTL Real Estate Investment Trusts
- Sector
- IMMP Health Care
- PSTL Real Estate
- Exchange
- IMMP Nasdaq
- PSTL Nasdaq
- Market Cap
- IMMP 251.8M
- PSTL 329.8M
- IPO Year
- IMMP N/A
- PSTL 2019
- Fundamental
- Price
- IMMP $1.67
- PSTL $15.77
- Analyst Decision
- IMMP Buy
- PSTL Strong Buy
- Analyst Count
- IMMP 1
- PSTL 1
- Target Price
- IMMP $7.00
- PSTL $17.75
- AVG Volume (30 Days)
- IMMP 88.5K
- PSTL 148.4K
- Earning Date
- IMMP 10-21-2025
- PSTL 11-03-2025
- Dividend Yield
- IMMP N/A
- PSTL 6.13%
- EPS Growth
- IMMP N/A
- PSTL 344.13
- EPS
- IMMP N/A
- PSTL 0.39
- Revenue
- IMMP $3,306,742.00
- PSTL $86,535,000.00
- Revenue This Year
- IMMP N/A
- PSTL $23.20
- Revenue Next Year
- IMMP $725.37
- PSTL $10.24
- P/E Ratio
- IMMP N/A
- PSTL $40.89
- Revenue Growth
- IMMP 31.28
- PSTL 26.43
- 52 Week Low
- IMMP $1.32
- PSTL $12.26
- 52 Week High
- IMMP $2.71
- PSTL $16.06
- Technical
- Relative Strength Index (RSI)
- IMMP 49.09
- PSTL 60.19
- Support Level
- IMMP $1.60
- PSTL $15.71
- Resistance Level
- IMMP $1.76
- PSTL $16.06
- Average True Range (ATR)
- IMMP 0.06
- PSTL 0.21
- MACD
- IMMP 0.01
- PSTL -0.04
- Stochastic Oscillator
- IMMP 47.06
- PSTL 48.21
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About PSTL Postal Realty Trust Inc.
Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.